Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles

Human Reproduction

Volumn 20, Issue 12, 2005, Pages 3318-3327

  Simon, C ^a,b,e   Oberye J ^c   Bellver, J ^b   Vidal, C ^b   Bosch, E ^b   Horcajadas, J A ^a   Murphy, C ^d   Adams, S ^d   Riesewijk, A ^c   Mannaerts, B ^c   Pellicer, A ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^c NV ORGANON   (Netherlands)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NONE   (Spain)

Author keywords

Endometrial receptivity; GnRH agonist; GnRH antagonist; Natural cycles

Indexed keywords

BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; GANIRELIX; GLUTATHIONE PEROXIDASE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PLACENTA PROTEIN 14; PROGESTERONE; PROGESTERONE RECEPTOR; RECOMBINANT FOLLITROPIN; STEROID RECEPTOR; TRANSCOBALAMIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; GENE EXPRESSION PROFILING; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MENSTRUAL CYCLE; NORMAL HUMAN; OOCYTE DONATION; RANDOMIZED CONTROLLED TRIAL;

EID: 28544445727     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei243     Document Type: Article

References (28)

1. Al Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 17,874-885.
2. Bourgain C and Devroey P (2003) The endometrium in stimulated cycles for IVF. Hum Reprod Update 9,515-522.
3. Casan EM, Raga F and Polan ML (1999) GnRH mRNA and protein expression in human preimplantation embryos. Mol Hum Reprod 5,234-239.
4. Develioglu OH, Hsiu JG, Nikas G, Toner JP, Oehninger S and Jones HW Jr (1999) Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril 71,1040-1047.
5. Devroey P, Abyholm T, Diedrich K, de Jong D, Hillensjo T, Hedon B, Itskovitz-Eldor J, Kahn J, Naether O, Olivennes F et al (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon™). Hum Reprod 13,3023-3031.
6. Friedler S, Schenker JG, Herman A and Lewin A (1996) The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: A critical review. Hum Reprod Update 2,323-335.
7. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E and Perrot-Applanat M (1988) Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 67,80-87.
8. Ghazeeri GS, Vongprachanh P and Kutteh WH (2000) The predictive value of five different urinary LH kits in detecting the LH surge in regularly menstruating women. Int J Fertil Women's Med 45,321-326.
9. Gonen Y and Casper RF (1990) Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fertil Embryo Transfer 7,146-152.
10. Hendrickson MR and Kempson RL (1994) The Uterine Corpus. In Sternberg SS, Antonioli DA, Mills SE, Carter D and Oberman HA (eds) Diagnostic Surgical Pathology. 2nd edn, Lippincott Raven, Philadelphia, pp 2091-2193.
11. Horcajadas JA, Riesewijk A, Polman J, van Os R, Mosselman S, Pellicer A and Simón C (2005) Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 11,195-205.
12. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B and Itskovitz-Eldor J (1999) High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze thaw cycles. Hum Reprod 14,2242-2244.
13. Kolb BA and Paulson RJ (1997) The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol 176,1262-1267.
14. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A and Devroey P (2002) Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78,1025-1029.
15. Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19, 2490-2496.
16. Leibovitz Z, Grinin V, Rabia R, Degani S, Shapiro I, Tal J, Eibschitz I, Harari O, Paltieli Y, Aharoni A et al (1999) Assessment of endometrial receptivity for gestation in patients undergoing in vitro fertilization, using endometrial thickness and the endometrium myometrium relative echogenicity coefficient. Ultrasound Obstet Gynecol 14,194-199.
17. Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J and Uzan S (2004) Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertil Steril 82,119-125.
18. Navot D, Scott RT, Droesch K, Veeck LL, Liu HC and Rosenwaks Z (1991) The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril 55,114-118.
19. Nikas G (1999) Pinopodes as markers of endometrial receptivity in clinical practice. Hum Reprod 14(Suppl 2),99-106.
20. Nikas G, Develioglu OH, Toner JP and Jones HW Jr (1999) Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles. Hum Reprod 14,787-792.
21. Noyes RW, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
22. Out HJ and Mannaerts BM (2002) The gonadotrophin-releasing hormone antagonist ganirelix history and introductory data. Hum Fertil (Camb) 5,G5-10.
23. Raga F, Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F and Polan ML (1999) The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140,3705-3712.
24. Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, Mosselman S and Simon C (2003) Gene expression profiling of human endometrial receptivity on days LH +2 versus LH +7 by microarray technology. Mol Hum Reprod 9,253-264.
25. Sharara FI, Lim J and McClamrock HD (1999) Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet 16,523-528.
26. Tamaya T, Murakami T and Okada H (1986) Concentrations of steroid receptors in normal human endometrium in relation to the day of the menstrual cycle. Acta Obstet Gynecol Scand 65,195-198.
27. Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A and Devroey P (1997) Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 67,521-526.
28. Wilcox AJ, Baird DD and Weinberg CR (1999) Time of implantation of the conceptus and loss of pregnancy. New Engl J Med 340,1796-1799.